| 摘要 |
<p>The invention provides novel inhibitors of IAP that are useful as therapeutic agents for treating malignancies where the compounds have the general formula I: wherein X, Y, A, R<SUB>1</SUB>, R<SUB>2</SUB>, R<SUB>3</SUB>, R<SUB>4</SUB>, R<SUB>4</SUB>', R<SUB>5</SUB>, R<SUB>5</SUB>', R<SUB>6 </SUB>and R<SUB>6</SUB>' are as described herein.</p> |
